AstraZeneca
AZN
AZN
1,088 hedge funds and large institutions have $35.3B invested in AstraZeneca in 2023 Q2 according to their latest regulatory filings, with 112 funds opening new positions, 337 increasing their positions, 388 reducing their positions, and 67 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.93% less ownership
Funds ownership: 32.76% → 31.82% (-0.93%)
13% less repeat investments, than reductions
Existing positions increased: 337 | Existing positions reduced: 388
21% less call options, than puts
Call options by funds: $641M | Put options by funds: $815M
Holders
1,088
Holding in Top 10
15
Calls
$641M
Puts
$815M
Top Buyers
| 1 | +$402M | |
| 2 | +$121M | |
| 3 | +$94M | |
| 4 |
EIP
Epoch Investment Partners
New York
|
+$73.1M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$59.5M |
Top Sellers
| 1 | -$427M | |
| 2 | -$272M | |
| 3 | -$252M | |
| 4 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$200M |
| 5 |
BlackRock
New York
|
-$196M |